-+ 0.00%
-+ 0.00%
-+ 0.00%

Chengdu Xingrui Jingxuan Therapeutics Launches Phase I Trial for Prostate Cancer Radiopharmaceutical

Reuters·12/30/2025 11:23:07

Please log in to view news